FDA Approved: CYTARABINE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cytarabine from Meitheal Pharmaceuticals Inc., completing a modification to the existing Cytarabine approval. The ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoblastic Lymphoma
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

SUPPL AP for CYTARABINE (CYTARABINE)